MRK Merck KGaA

141.95EUR+4.34%Mkt Cap: 64.30B $P/E: 24.96

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic…

HeadlineSourceTime
Yesterday
WELT
boerse.de
WELT
finanzen.net
finanzen.ch
Older
WELT
finanzen.net
Börse Social
WELT
AD HOC NEWS
WELT
finanzen.net
finanzen.ch
simplywall.st
WELT
FinanzNachrichten.de
XTB.com
Börse Social
finanzen.net
finanzen.net
WELT
finanzen.ch
Börse Social
finanzen.net
Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package

Bio-Techne Corporation (NASDAQ:TECH) shareholders voted on September 23 to approve the company’s acquisition by Merck KGaA of Darmstadt, Germany. The German group is paying $73 a share in cash, valuing the business at about $11.3 billion including debt. They also voted down the executive compensation proposal attached to the deal, which is an unusual pairing. […]

Insider Monkey
WELT
simplywall.st
simplywall.st
finanzen.net
WELT
Finanzen.net
boerse.de
finanzen.net
Finanzen.net
Merck KGaA (XTRA:MRK) Clears Key Acquisition Hurdle After Shareholder Approval

Merck KGaA (XTRA:MRK) has received shareholder approval from Bio-Techne investors for its planned acquisition of the US life sciences group. The vote clears a major corporate hurdle in the transaction process, with completion still subject to remaining regulatory reviews. The planned merger is expected to broaden the combined product set and customer reach across multiple stages of the life sciences workflow. The Bio-Techne shareholder approval is important, but it should not be the only...

Simply Wall St.
WELT
MarketScreener Deutschland
Investing.com Deutsch
WELT
WELT
boerse.de
WELT
finanzen.net
WELT
finanzen.ch
finanzen.net
boerse.de
WELT
boerse.de
WELT